Editorial: The Role of Complement in Tumors.
作者信息
Rolfe Barbara E, Pio Ruben, Woodruff Trent M, Markiewski Maciej M, Manthey Helga D
机构信息
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.
Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
出版信息
Front Immunol. 2020 Feb 11;11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: The Role of Complement in Tumors.社论：补体在肿瘤中的作用
Front Immunol. 2020 Feb 11;11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020.
2
The complement system in cancer: Ambivalence between tumour destruction and promotion.癌症中的补体系统：肿瘤破坏与促进之间的矛盾
Immunobiology. 2017 Jan;222(1):45-54. doi: 10.1016/j.imbio.2015.11.008. Epub 2015 Nov 28.
3
Complement as a Biological Tool to Control Tumor Growth.补体作为控制肿瘤生长的生物学工具。
Front Immunol. 2018 Sep 25;9:2203. doi: 10.3389/fimmu.2018.02203. eCollection 2018.
4
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.癌症单克隆抗体治疗中补体的调节及其活性的调控
MAbs. 2014;6(5):1133-44. doi: 10.4161/mabs.29670. Epub 2014 Oct 30.
5
6
Complement in antibody-based tumor therapy.基于抗体的肿瘤治疗中的补体
Crit Rev Immunol. 2014;34(3):199-214. doi: 10.1615/critrevimmunol.2014009761.
7
Editorial: Complement and Immunotherapeutics.社论：补体与免疫疗法
Front Immunol. 2021 Feb 24;12:663459. doi: 10.3389/fimmu.2021.663459. eCollection 2021.
8
The role of complement in mAb-based therapies of cancer.补体在癌症单抗治疗中的作用。
Methods. 2014 Jan 1;65(1):18-27. doi: 10.1016/j.ymeth.2013.07.027. Epub 2013 Jul 22.
9
The role of the complement system in cancer.补体系统在癌症中的作用。
J Clin Invest. 2017 Mar 1;127(3):780-789. doi: 10.1172/JCI90962.
10
Complement function in mAb-mediated cancer immunotherapy.单克隆抗体介导的癌症免疫治疗中的补体功能。
Trends Immunol. 2004 Mar;25(3):158-64. doi: 10.1016/j.it.2004.01.008.
引用本文的文献
1
Novel FABP4C1q macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK/JAK/STAT axis.新型 FABP4C1q 巨噬细胞通过 AMPK/JAK/STAT 轴增强抗肿瘤免疫，并与 NSCLC 新辅助帕博利珠单抗和化疗的反应相关。
Cell Death Dis. 2024 Oct 1;15(10):717. doi: 10.1038/s41419-024-07074-x.
2
Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma.治疗性高温通过 HSP A5/NFκB/CD55 通路调节鼻咽癌中补体 C3 的激活并抑制肿瘤发展。
Clin Exp Immunol. 2023 Jul 21;213(2):221-234. doi: 10.1093/cei/uxad060.
3
Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance.免疫补体标志物C3/C5/C3AR1/C5AR1与肿瘤免疫逃逸及治疗耐药性的泛癌分析
Cancers (Basel). 2021 Aug 16;13(16):4124. doi: 10.3390/cancers13164124.
本文引用的文献
1
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.评估有资格接受和对检查点抑制剂免疫治疗药物有反应的美国癌症患者的百分比。
JAMA Netw Open. 2019 May 3;2(5):e192535. doi: 10.1001/jamanetworkopen.2019.2535.
2
C1q: A fresh look upon an old molecule.C1q：对一个古老分子的全新审视。
Mol Immunol. 2017 Sep;89:73-83. doi: 10.1016/j.molimm.2017.05.025. Epub 2017 Jun 7.
3
New concepts on the therapeutic control of complement anaphylatoxin receptors.补体过敏毒素受体治疗性控制的新概念。
Mol Immunol. 2017 Sep;89:36-43. doi: 10.1016/j.molimm.2017.05.015. Epub 2017 May 30.
4
Keeping It All Going-Complement Meets Metabolism.持续运转——补体与新陈代谢相遇
Front Immunol. 2017 Jan 18;8:1. doi: 10.3389/fimmu.2017.00001. eCollection 2017.
5
Complement System Part I - Molecular Mechanisms of Activation and Regulation.补体系统 第一部分——激活与调节的分子机制
Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015.
6
Complement System Part II: Role in Immunity.补体系统第二部分：在免疫中的作用。
Front Immunol. 2015 May 26;6:257. doi: 10.3389/fimmu.2015.00257. eCollection 2015.
7
Complement modulation of T cell immune responses during homeostasis and disease.稳态和疾病期间T细胞免疫反应的补体调节
J Leukoc Biol. 2014 Nov;96(5):745-56. doi: 10.1189/jlb.3MR0214-109R. Epub 2014 Sep 10.
8
A perspective on cancer cell metastasis.癌症细胞转移的观点。
Science. 2011 Mar 25;331(6024):1559-64. doi: 10.1126/science.1203543.
9
Cancer and complement.癌症与补体。
Nat Biotechnol. 2008 Dec;26(12):1348-9. doi: 10.1038/nbt1208-1348.
10
Modulation of the antitumor immune response by complement.补体对抗肿瘤免疫反应的调节
Nat Immunol. 2008 Nov;9(11):1225-35. doi: 10.1038/ni.1655. Epub 2008 Sep 28.
Zotero 插件